Scientists at the University of Pittsburgh have identified "fragile" immune cells as a key driver of serious side effects in cancer immunotherapy patients. Published in Cell, the study found that a Western-style diet and gut microbiome composition can worsen these reactions — and that switching to a high-fiber diet or blocking a specific immune protein may reverse them.
Up to 40% of cancer patients on immune checkpoint inhibitors — a major class of immunotherapy drugs — experience serious immune-related side effects that can land them in the hospital and force them off treatment. Now, researchers at the University of Pittsburgh think they've found a key culprit: unstable regulatory T cells made fragile by lifestyle factors like diet and gut microbiome composition.
The team, publishing in Cell, developed the first mouse model of these adverse events without relying on genetic modifications. By feeding mice a Western-style diet (low fiber, high fat, and processed carbs) before and during immunotherapy, they replicated the immune and microbiome patterns seen in human patients with severe side effects. Restoring the stability of these "fragile" regulatory T cells — either by blocking a specific immune signaling protein, switching to a high-fiber diet, or using metabolite supplements — significantly reduced the severity of reactions.
Key Takeaways:
Why it matters: This research could reshape how oncologists manage immunotherapy side effects — potentially through dietary interventions or new targeted drugs — allowing more patients to stay on life-saving treatment.
